Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Recall Of Millions Of Ellume COVID-19 Tests High-Risk Class I, FDA Says
It’s the second coronavirus diagnostic to be slapped with a class I recall label
Nov 10 2021
•
By
Shawn M. Schmitt
The recalled COVID-19 test from Ellume • Source: Alamy
More from Recalls
More from Policy & Regulation